About this compound
Tesamorelin is a synthetic analogue of the complete 44-residue human GHRH sequence, modified with a trans-3-hexenoyl group at the N-terminus.
Studied in
- GH/IGF-1 axis
- Adipose distribution models
- Endocrine signalling
Compound identity
| Compound | Tesamorelin |
|---|---|
| CAS number | 901758-09-6 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5,135.9 Da |
Specifications
- Purity method: HPLC
- Appearance: Lyophilized powder
- Solubility: Reconstitute per protocol; see Supplies for diluents.
- We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.
Endocrine
Tesamorelin
A stabilised growth-hormone releasing peptide.
What the research targets
Studied in growth-hormone research, including adipose-tissue distribution models.
Research use only
Supplied to qualified professionals and institutions for laboratory research. Not a drug, supplement or cosmetic, and not for human or veterinary use. We publish no dosing or administration guidance of any kind.
Supply formats
Buy one, or a case of ten.
Single unit
One unit.
10 mgVial
PS-9789916-10-MG
On verified account
Case — 10-pack
10 of the same size, at the 10-pack price.
Case · 10 × 10 mg
10-pack price — 10 × one unit, per vial.
PS-9789916-C10-10-MG
On verified account
One-time verification of professional or institutional affiliation. No payment is taken on this site.
From the research library
All articlesCited summaries of the published work behind Tesamorelin — what was studied, in which model, and what was measured.